⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4175824 | 0.54 | — | — | |
| SCHEMBL2088 | 0.51 | — | — | |
| SCHEMBL4056 | 0.46 | — | — | |
| SCHEMBL976278 | 0.46 | — | — | |
| SCHEMBL21590148 | 0.46 | — | — | |
| SCHEMBL25204735 | 0.46 | — | — | |
| SCHEMBL21722216 | 0.46 | — | — | |
| SCHEMBL893 | 0.46 | — | — | |
| SCHEMBL6559802 | 0.38 | — | — | |
| SCHEMBL11097659 | 0.38 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117631451-A | Colored photosensitive resin composition, color filter and image display device | 东友精细化工有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-117396563-A | Compounds of formula (I) | 住友化学株式会社 | 2024-01-12 | — | — | CN | disclosed |
| CN-117255831-A | Compounds of formula (I) | 住友化学株式会社 | 2023-12-19 | — | — | CN | disclosed |
| CN-111902400-A | Aromatic derivatives, process for their preparation and their medical use | 保仕健生物科技(上海)有限公司 | 2020-11-06 | — | — | CN | disclosed |
| EP-2729475-B1 | Carboxylic acid derivatives with an oxazolo[4,5-d]pyrimidine ring | SANOFI SA (FR) | 2015-06-10 | — | — | EP | disclosed |
| US-8735402-B2 | Cycloalkyloxycarboxylic acid derivatives | SANOFI (FR) | 2014-05-27 | — | — | US | disclosed |
| US-8557978-B2 | Cross-linked glycopeptide-cephalosporin antibiotics | THERAVANCE, INC. (US) | 2013-10-15 | — | — | US | disclosed |
| EP-2560634-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | Piramal Enterprises Limited (IN) | 2013-02-27 | — | — | EP | disclosed |
| US-20130023545-A1 | CYCLOALKYLOXYCARBOXYLIC ACID DERIVATIVES | SANOFI (FR) | 2013-01-24 | — | — | US | disclosed |
| EP-1692102-B1 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS | CHEMOCENTRYX INC (US) | 2012-11-21 | — | — | EP | disclosed |
| US-20040266666-A1 | Cross-linked glycopeptide-cephalosporin antibiotics | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2004-12-30 | — | — | US | disclosed |
| WO-2004113350-A1 | CROSS-LINKED GLYCOPEPTIDE - CEPHALOSPORIN ANTIBIOTICS | THERAVANCE, INC. (US) | 2004-12-29 | — | — | WO | disclosed |
| US-20040170634-A1 | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors | CHEMOCENTRYX, INC. (US) | 2004-09-02 | — | — | US | disclosed |
| EP-1434779-A2 | CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS | Theravance, Inc. (US) | 2004-07-07 | — | — | EP | disclosed |
| US-20040033939-A1 | Cross-linked glycopeptide-cephalosporin antibiotics | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2004-02-19 | — | — | US | disclosed |
| WO-2003099858-A1 | CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS | THERAVANCE, INC. (US) | 2003-12-04 | — | — | WO | disclosed |
| US-20030130173-A1 | Cross-linked glycopeptide-cephalosporin antibiotics | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2003-07-10 | — | — | US | disclosed |
| WO-2003031449-A2 | CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS | THERAVANCE, INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| EP-0644872-B1 | ORNITHINE DECARBOXYLASE INHIBITING CYCLIC AMINOOXY COMPOUNDS | CIBA GEIGY AG (CH) | 1997-03-19 | — | — | EP | disclosed |
| US-5516806-A | ANTITUMOR | CIBA-GEIGY CORPORATION (US) | 1996-05-14 | — | — | US | disclosed |